NCT02225184View on ClinicalTrials.gov

Impact of Delta Opioid Receptor Gene (OPRD1) Variations on Treatment Outcome in African Americans

CompletedOBSERVATIONAL
Enrollment

81

Participants

Timeline

Start Date

August 23, 2014

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Genetic Underpinning of Substance AbusePolymorphism-geneticDrug Abuse/DependenceOpiod-Related Disorders
Trial Locations (1)

21224

National Institute on Drug Abuse, Baltimore

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT02225184 - Impact of Delta Opioid Receptor Gene (OPRD1) Variations on Treatment Outcome in African Americans | Biotech Hunter | Biotech Hunter